MEDI 167-Discovery of the highly potent, selective and orally bioavailable CCR9 antagonist CCX282-B - Ungashe, S; Wei, Z; Rubas, W; Lai, N; Ertl, L; Baumgart, T; Wang, H; Miao, Z; Hor, S; Premack, B; Moore, J; Sullivan, E; et al. (ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008)